Literature DB >> 22231928

Recent advances in stealth coating of nanoparticle drug delivery systems.

Zohreh Amoozgar1, Yoon Yeo.   

Abstract

Modifying surfaces of nanoparticles (NPs) with polyethylene glycol (PEG), the so-called PEGylation, is the most commonly used method for reducing premature clearance of NPs from the circulation. However, several reports point out that PEGylation may negatively influence the performance of NPs as a drug carrier. Alternative surface modification strategies, including substitute polymers, conditional removal of PEG, and biomimetic surface modification, may provide solutions for the limitations of PEG.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22231928      PMCID： PMC3288878          DOI： 10.1002/wnan.1157

Source DB:  PubMed          Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol        ISSN： 1939-0041


  165 in total

1.  Reversibly stabilized multifunctional dextran nanoparticles efficiently deliver doxorubicin into the nuclei of cancer cells.

Authors:  Yu-Ling Li; Li Zhu; Zhaozhong Liu; Ru Cheng; Fenghua Meng; Jing-Hao Cui; Shun-Jun Ji; Zhiyuan Zhong
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

2.  Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes.

Authors:  E T Dams; P Laverman; W J Oyen; G Storm; G L Scherphof; J W van Der Meer; F H Corstens; O C Boerman
Journal:  J Pharmacol Exp Ther       Date:  2000-03       Impact factor: 4.030

3.  New types of synthetic infusion solutions. I. Investigation of the effect of solutions of some hydrophilic polymers on blood.

Authors:  J Kopecek; L Sprincl; D Lïm
Journal:  J Biomed Mater Res       Date:  1973-03

4.  Direct comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: is surface coating with polyethylene glycol beneficial?

Authors:  R L Hong; C J Huang; Y L Tseng; V F Pang; S T Chen; J J Liu; F H Chang
Journal:  Clin Cancer Res       Date:  1999-11       Impact factor: 12.531

5.  Pegylation of liposomes favours the endosomal degradation of the delivered phosphodiester oligonucleotides.

Authors:  K Remaut; B Lucas; K Braeckmans; J Demeester; S C De Smedt
Journal:  J Control Release       Date:  2006-11-07       Impact factor: 9.776

6.  Doxorubicin bound to a HPMA copolymer carrier through hydrazone bond is effective also in a cancer cell line with a limited content of lysosomes.

Authors:  B Ríhová; T Etrych; M Pechar; M Jelínková; M Stastný; O Hovorka; M Kovár; K Ulbrich
Journal:  J Control Release       Date:  2001-07-06       Impact factor: 9.776

Review 7.  Mechanisms of drug resistance in cancer chemotherapy.

Authors:  Y A Luqmani
Journal:  Med Princ Pract       Date:  2005       Impact factor: 1.927

8.  In vivo biological evaluation of high molecular weight hyperbranched polyglycerols.

Authors:  Rajesh K Kainthan; Donald E Brooks
Journal:  Biomaterials       Date:  2007-08-15       Impact factor: 12.479

9.  Doxorubicin-loaded polymeric micelle overcomes multidrug resistance of cancer by double-targeting folate receptor and early endosomal pH.

Authors:  Dongin Kim; Eun Seong Lee; Kyung Taek Oh; Zhong Gao Gao; You Han Bae
Journal:  Small       Date:  2008-11       Impact factor: 13.281

10.  In vivo evaluation of doxorubicin-loaded polymeric micelles targeting folate receptors and early endosomal pH in drug-resistant ovarian cancer.

Authors:  Dongin Kim; Zhong Gao Gao; Eun Seong Lee; You Han Bae
Journal:  Mol Pharm       Date:  2009 Sep-Oct       Impact factor: 4.939
View more
  80 in total

Review 1.  Nanoparticle Probes for the Detection of Cancer Biomarkers, Cells, and Tissues by Fluorescence.

Authors:  Alyssa B Chinen; Chenxia M Guan; Jennifer R Ferrer; Stacey N Barnaby; Timothy J Merkel; Chad A Mirkin
Journal:  Chem Rev       Date:  2015-08-27       Impact factor: 60.622

Review 2.  Effect of surface properties on liposomal siRNA delivery.

Authors:  Yuqiong Xia; Jie Tian; Xiaoyuan Chen
Journal:  Biomaterials       Date:  2015-12-02       Impact factor: 12.479

Review 3.  High-Density Lipoproteins: Nature's Multifunctional Nanoparticles.

Authors:  Rui Kuai; Dan Li; Y Eugene Chen; James J Moon; Anna Schwendeman
Journal:  ACS Nano       Date:  2016-02-25       Impact factor: 15.881

4.  Clinical Cancer Nanomedicine.

Authors:  Joy Wolfram; Mauro Ferrari
Journal:  Nano Today       Date:  2019-03-06       Impact factor: 20.722

Review 5.  Lysosomal enzyme replacement therapies: Historical development, clinical outcomes, and future perspectives.

Authors:  Melani Solomon; Silvia Muro
Journal:  Adv Drug Deliv Rev       Date:  2017-05-11       Impact factor: 15.470

Review 6.  PEGylation: a promising strategy to overcome challenges to cancer-targeted nanomedicines: a review of challenges to clinical transition and promising resolution.

Authors:  Zahid Hussain; Shahzeb Khan; Muhammad Imran; Muhammad Sohail; Syed Wadood Ali Shah; Marcel de Matas
Journal:  Drug Deliv Transl Res       Date:  2019-06       Impact factor: 4.617

Review 7.  Application of polysaccharides for surface modification of nanomedicines.

Authors:  Kyung-Oh Doh; Yoon Yeo
Journal:  Ther Deliv       Date:  2012-12

8.  The effect of hyperbranched polyglycerol coatings on drug delivery using degradable polymer nanoparticles.

Authors:  Yang Deng; Jennifer K Saucier-Sawyer; Christopher J Hoimes; Junwei Zhang; Young-Eun Seo; Jillian W Andrejecsk; W Mark Saltzman
Journal:  Biomaterials       Date:  2014-05-09       Impact factor: 12.479

Review 9.  Strategies for improving drug delivery: nanocarriers and microenvironmental priming.

Authors:  Ayesha Khalid; Stefano Persano; Haifa Shen; Yuliang Zhao; Elvin Blanco; Mauro Ferrari; Joy Wolfram
Journal:  Expert Opin Drug Deliv       Date:  2016-10-11       Impact factor: 6.648

Review 10.  Vascular-targeted nanocarriers: design considerations and strategies for successful treatment of atherosclerosis and other vascular diseases.

Authors:  William J Kelley; Hanieh Safari; Genesis Lopez-Cazares; Omolola Eniola-Adefeso
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2016-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.